payer

Market Access

India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.

News

Repatha cuts cardio events, but not mortality.

News

Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.